Investor
Optimized diabetic retinopathy management offers a unique
opportunity to improve care and create value 
For Investors

Inoveon is a premier early stage, venture-backed medical services company providing digital iScan services to detect stage and monitor diabetic retinopathy in the primary diabetes care setting. Inoveon's approach is based on Quality, Performance and Economic Value. The Company is led by a diverse. experienced and entrepreneurial management team.

Inoveon delivers its service by establishing productive partnerships with large. well respected primary care and endocrinology clinics helping them increase patient compliance with evidence-based guidelines and generate additional practice income.


navigator
Quality • Performance • Economic Value


About Inoveon  |  News and Events  |  Contact Us  |  Patients  |  Medical Professionals  |  Investor/Analyst

© 2008 Inoveon Corporation.  The names and distinctive graphic styling of inoveon, iContact, iSite, iScan, and iScore are trademarks of Inoveon Corporation and may not be used without written permission. Please review the Terms of Use.